Neoleukin Therapeutics Enters Reverse Merger Agreement with Neurogene
Shares of biopharmaceutical company Neoleukin Therapeutics experienced a surge in premarket trading on Tuesday following the announcement of an all-stock reverse merger with privately held genetic-medicines company Neurogene. Under the…